1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc. XNAS: IRD
2.83 0.02 (0.71%)
1.2M

XNAS 27 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Opus Genetics Inc - IRD - stock price prediction, stock price target, analyst ratings from 11 analysts

Opus Genetics Inc has a share price target of US$ 8, revenue growth forecast of 22.8%, and profit growth estimate of 30.2% for FY25, based on top 11 analyst calls.